IL10 and COVID-19: Interestingly, several studies have predicted poor outcomes in patients with COVID-19, suggesting that dysregulation of IL-10 can occur during states of excessive immune cell activation, such as the cytokine storm seen with SARS-CoV-2 infection [55].